Drug selection and the management of corticosteroid-related diabetes mellitus (Q33722865)

28 July 2017

1 reference

title

Drug selection and the management of corticosteroid-related diabetes mellitus (English)

1 reference

28 July 2017

Hoogwerf B

1 reference

28 July 2017

Danese RD

series ordinal

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Rheumatic Diseases Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

489-505

1 reference

Nutrition recommendations and principles for people with diabetes mellitus

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

1 reference

7 January 2021

Diabetes management during glucocorticoid therapy for nonendocrine disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

1 reference

7 January 2021

Medical problems occurring after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Nutrition principles for the management of diabetes and related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Posttransplant diabetes in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Clinical and metabolic characteristics of hyperosmolar nonketotic coma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Alternate day corticosteroid causes alternate day hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

1 reference

7 January 2021

Diabetes management in special situations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Urinary C-Peptide: A Simple Measure of Integrated Insulin Production with Emphasis on the Effects of Body Size, Diet, and Corticosteroids*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Urinary C-peptide as a measure of beta-cell function after a mixed meal in healthy subjects: comparison of four-hour urine C-peptide with serum insulin and plasma C-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Diabetes. Causes of insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

alpha-Glucosidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

1 reference

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Exercise in individuals with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Section Review: Oncologic, Endocrine & Metabolic: Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Clustering of heart disease risk factors in diabetic compared to nondiabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

Glucose control lowers the risk of wound infection in diabetics after open heart operations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970083-1

1 reference

7 January 2021

10.1016/S0889-857X(05)70083-1

Identifiers

DOI

1 reference

28 July 2017

1 reference